D-0620-2020 Class II Terminated
FDA drug recall D-0620-2020 was initiated by SCA Pharmaceuticals, LLC on November 26, 2019 and is designated Class II. Reason for recall: Presence of Foreign Substance: Foreign material found inside the vial (manufacturer). The recall status is terminated (terminated February 7, 2020). Affected quantity: 1363 syringes.
Recall Details
- Product Type
- Drugs
- Report Date
- December 18, 2019
- Initiation Date
- November 26, 2019
- Termination Date
- February 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1363 syringes
Product Description
Lidocaine HCl 2% 5 mL, Syringe, Rx Only, SCA Pharmaceuticals 755 Rainbow Road Windsor, CT 08695 NDC 70004-0723-09
Reason for Recall
Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).
Distribution Pattern
nationwide
Code Information
1219012595 29-Dec-19 1219012647 01-Jan-20